Elekta AB (EKTA B) - Financial and Strategic SWOT Analysis Review

Elekta AB (EKTA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Elekta AB (Elekta) is a medical technology company that offers image guided clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotactic system; fully integrated stereotactic radiation therapy system; system for volumetric arc modulated therapy (VMAT); image guided radiation therapy (IGRT) systems; advanced digital treatment systems; treatment planning systems; electronic brachy therapy for skin cancer; and automated remote after loading platform. It also offers oncology information systems for radiation oncology and medical oncology, treatment planning software, cancer registry and soft tissue visualization software, among others. The company operates in North America, Europe, the Middle East, Africa and Asia-Pacific. Elekta is headquartered in Stockholm, Sweden.

Elekta AB Key Recent Developments

Aug 22,2019: Elekta: Interim report, MayJuly 2019/20
Jun 13,2019: Elekta increases focus on digitization - hires Sukhveer Singh to drive Elekta digital strategy
May 29,2019: Elekta: Year-end report May-April 2018/19
Mar 28,2019: ATOMEXPO 2019 to feature discussion on the possibilities of nuclear medicine around the World
Feb 22,2019: Elekta: Interim report May-January 2018/19

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables
List of Figures
Section 1 - About the Company
Elekta AB - Key Facts
Elekta AB - Key Employees
Elekta AB - Key Employee Biographies
Elekta AB - Major Products and Services
Elekta AB - History
Elekta AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Elekta AB - Business Description
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, Middle East and Africa
Performance
Geographical Segment: North and South America
Performance
R&D Overview
Elekta AB - SWOT Analysis
SWOT Analysis - Overview
Elekta AB - Strengths
Elekta AB - Weaknesses
Elekta AB - Opportunities
Elekta AB - Threats
Elekta AB - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Elekta AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Elekta AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
Elekta AB, Recent Deals Summary
Section 5 Companys Recent Developments
Aug 22, 2019: Elekta: Interim report, MayJuly 2019/20
Jun 13, 2019: Elekta increases focus on digitization - hires Sukhveer Singh to drive Elekta digital strategy
May 29, 2019: Elekta: Year-end report May-April 2018/19
Mar 28, 2019: ATOMEXPO 2019 to feature discussion on the possibilities of nuclear medicine around the World
Feb 22, 2019: Elekta: Interim report May-January 2018/19
Nov 29, 2018: Elekta: Interim report May-October 2018/19 Q2
Sep 05, 2018: Elekta celebrates inauguration of new global radiotherapy innovation center
Aug 30, 2018: Elekta: Interim report May-July 2018/19
Jul 25, 2018: Elekta Implements PTCs ThingWorx on Microsoft Azure for Next Generation Remote Service
Jul 13, 2018: Elekta to donate advanced radiation therapy machine to Jordans Al Bashir Hospital
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

List of Tables
Elekta AB, Key Facts
Elekta AB, Key Employees
Elekta AB, Key Employee Biographies
Elekta AB, Major Products and Services
Elekta AB, History
Elekta AB, Other Locations
Elekta AB, Subsidiaries
Elekta AB, Key Competitors
Elekta AB, Ratios based on current share price
Elekta AB, Annual Ratios
Elekta AB, Annual Ratios (Cont...1)
Elekta AB, Annual Ratios (Cont...2)
Elekta AB, Interim Ratios
Elekta AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Elekta AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
Elekta AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures
Elekta AB, Performance Chart (2015 - 2019)
Elekta AB, Ratio Charts
Elekta AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
Elekta AB, Medical Equipment, Deals by Type, 2013 to YTD 2019

Elekta AB (EKTA B) - Product Pipeline Analysis, 2017 Update

Elekta AB (Elekta) is a medical technology company that offers image guided and stereotactic clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer

USD 750 View Report

Elekta AB (EKTA B) - Financial and Strategic SWOT Analysis Review

Elekta AB (EKTA B) - Financial and Strategic SWOT Analysis Review market research report available in single user pdf license with Aarkstore Enterprise at USD 125

USD 125 View Report

Elekta AB (EKTA B) - Product Pipeline Analysis, 2017 Update

Elekta AB (Elekta) is a medical technology company that offers image guided and stereotactic clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available